Yichang Humanwell Pharmaceutical Co Ltd has recently secured regulatory approval from Germany’s Federal Institute for Drugs and Medical Devices, and Malta’s health authorities for its Hydromorphone Hydrochloride injection, marking the company’s first injectable authorized for sale by the European Union.

　　As an opioid analgesic, Hydromorphone Hydrochloride is used to alleviate moderate or severe pain from surgeries, cancer, trauma, and other conditions, including biliary and renal colic, burns, and heart attacks. The EU-approved painkiller, with its quality meeting EU standards, paves the way for the company’s expansion in the European market. (Reporter/Wang Ying, Correspondents/Ren Shujuan and Chen Ran)